KALPALATHA GUNTUPALLI to Sepsis
This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Sepsis.
Connection Strength
0.607
-
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013 Mar; 41(3):706-16.
Score: 0.299
-
Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis. N Engl J Med. 2021 04 15; 384(15):1424-1436.
Score: 0.130
-
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial. Crit Care Med. 2015 Sep; 43(9):1832-8.
Score: 0.089
-
Whole-body CO2 production as an index of the metabolic response to sepsis. Shock. 2009 Jul; 32(1):23-8.
Score: 0.058
-
Acute respiratory distress syndrome. Crit Care Clin. 1997 Jul; 13(3):503-21.
Score: 0.025
-
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30; 334(22):1417-21.
Score: 0.006